Gabriela Gruia - May 5, 2023 Form 3 Insider Report for Aprea Therapeutics, Inc. (APRE)

Role
Director
Signature
/s/ John P. Hamill, Attorney-in-fact
Stock symbol
APRE
Transactions as of
May 5, 2023
Transactions value $
$0
Form type
3
Date filed
5/8/2023, 05:16 PM
Previous filing
Jun 6, 2022
Next filing
Jun 15, 2023

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney